Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods relating to anti-IGF-1 receptor antibodies

Compositions and methods relating to anti-IGF-1 receptor antibodies

US Patent 8895008 · Granted Nov 25, 2014

Estimated economic value: $549,708,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Calcitonin gene-related peptide (CGRP) antagonist antibodies2023
Immunotherapy using antibodies that bind programmed death ligand-1 (PD-L1)2022
Cancer treatment using antibodies that bind cytotoxic T-lymphocyte antigen-4 (CT2022
Combination of glucagon receptor antagonists and PI3K pathway inhibitors for the2022
Immunotherapy using antibodies that bind Programmed Death 1 (PD-1)2022
Anti-OX40 antibodies and methods of activating OX402022
Methods and compositions for treating tumor diseases2021
Dual receptor antagonistic antigen-binding proteins and uses thereof2021
Dual receptor antagonistic antigen-binding proteins and uses thereof2019
Cannabinoid receptor-1 (CB1) monoclonal antibodies2019
Devices and methods for implementing dynamic collaborative workflow systems2018
Compositions and methods relating to anti-IGF-1 receptor antibodies2018